{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "572a42e3",
   "metadata": {},
   "source": [
    "## 1.Two Gene Set Variation Indexes as Potential Diagnostic Tools for Sepsis.\"\n",
    "\n",
    "Objective:\n",
    "\n",
    "To identify and validate gene expression-based diagnostic tools for sepsis using Gene Set Variation Analysis (GSVA) indexes derived from publicly available datasets.\n",
    "\n",
    "Data Collection:\n",
    "\n",
    "Analyzed three Gene Expression Omnibus (GEO) datasets (GSE57065, GSE69528, GSE95233) for differentially expressed genes (DEGs) in sepsis and non-sepsis blood samples.\n",
    "\n",
    "Identification of Key Gene Sets:DEGs were categorized as upregulated and downregulated.\n",
    "\n",
    "The most functionally similar genes were grouped into two diagnostic gene sets:\n",
    "\n",
    "Upregulated Genes: **OLFM4, ORM1, CEP55, S100A12, S100P, LRG1, CEACAM8, MS4A4A, PLSCR1, IL1R2**.\n",
    "\n",
    "Downregulated Genes: **THEMIS, IL2RB, CD2, IL7R, CD3E, KLRB1, PVRIG, CCR3, TGFBR3, PLEKHA1**.\n",
    "\n",
    "Gene Set Variation Analysis (GSVA):GSVA was used to calculate enrichment scores for the two gene sets in each sample.\n",
    "\n",
    "Receiver Operating Characteristic (ROC) curve analysis assessed diagnostic accuracy.\n",
    "Validation:An independent dataset (GSE123729) was used to validate the diagnostic utility of the upregulated GSVA index.\n",
    "\n",
    "Functional Enrichment Analysis:\n",
    "\n",
    "Kyoto Encyclopedia of Genes and Genomes (KEGG) and sub-pathway analyses were performed to identify pathways associated with the identified gene sets.\n",
    "\n",
    "Results:\n",
    "\n",
    "\n",
    "Diagnostic Accuracy:\n",
    "\n",
    "The upregulated GSVA index showed high diagnostic performance with ROC area under the curve (AUC) values ranging from 0.77 to 0.98 across datasets.\n",
    "\n",
    "Validation using GSE123729 confirmed its utility with an AUC of 0.93.\n",
    "\n",
    "Biological Pathways:\n",
    "\n",
    "Upregulated Genes: Enriched in pathways like complement and coagulation cascades, MAPK signaling, and p53 signaling.\n",
    "\n",
    "Downregulated Genes: Associated with Jak-STAT, PI3K-Akt, and T-cell receptor signaling pathways.\n",
    "\n",
    "Key Findings:\n",
    "\n",
    "Genes like OLFM4, ORM1, and IL1R2 were highlighted as promising biomarkers due to their roles in immune modulation and inflammatory responses.\n",
    "The two GSVA indexes successfully differentiated sepsis from non-sepsis samples.\n",
    "\n",
    "Diagnostic and Prognostic Value:\n",
    "\n",
    "Diagnostic: Both GSVA indexes demonstrated robust diagnostic potential for distinguishing sepsis from non-sepsis samples.\n",
    "\n",
    "  \n",
    "\n",
    "## 2. To develop a transcriptomic biomarker panel for diagnosing sepsis by quantifying systemic inflammation, distinguishing infection from non-infectious inflammation, and predicting clinical outcomes.\n",
    "\n",
    "\n",
    "Study Cohorts:\n",
    "\n",
    "Training Set: 96 ICU patients with systemic inflammation to identify key transcriptomic markers.\n",
    "Verification Set: 72 patients across various inflammation states to validate marker significance.\n",
    "Confirmation Set: 246 patients from two cohorts (Germany and Greece) to confirm biomarker utility using RT-qPCR.\n",
    "\n",
    "Techniques:\n",
    "\n",
    "Microarray Analysis: Screening of thousands of transcripts for differential expression.\n",
    "RT-qPCR: Validation of selected transcripts for practical clinical application.\n",
    "Gene Expression Score (GES): Composite measure of up-regulated and down-regulated genes quantifying inflammation.\n",
    "\n",
    "Statistical Analyses:\n",
    "\n",
    "Linear discriminant analysis (LDA) for marker selection.\n",
    "Receiver operating characteristic (ROC) analysis to evaluate diagnostic performance.\n",
    "\n",
    "Results:\n",
    "\n",
    "Diagnostic Genes Identified:\n",
    "\n",
    "Up-regulated Genes:\n",
    "\n",
    "**TLR5** (Toll-like receptor 5): Pathogen recognition.\n",
    "\n",
    "**CD59** (Protectin): Complement regulation.\n",
    "\n",
    "**CLU** (Clusterin): Complement lysis inhibition.\n",
    "\n",
    "Down-regulated Genes:\n",
    "\n",
    "**FGL2** (Fibrinogen-like 2): Immune regulation.\n",
    "\n",
    "**IL7R** (Interleukin-7 receptor): Lymphocyte development.\n",
    "\n",
    "**HLA-DPA1** (MHC class II, DP alpha1): Antigen presentation.\n",
    "\n",
    "**CPVL** (Carboxypeptidase, vitellogenic-like): Inflammation regulation.\n",
    "\n",
    "Performance Metrics:\n",
    "\n",
    "Gene Expression Score (GES):AUC: 0.812 for differentiating infection from non-infection.\n",
    "Good sensitivity but limited specificity.\n",
    "\n",
    "Validation Findings:\n",
    "Infection Detection:Higher GES in patients with infection compared to those without.\n",
    "Both UP and DOWN genomic scores correlated with infection status.\n",
    "\n",
    "Prognostic Value:\n",
    "A significant early decrease (>17%) in DOWN score within 24 hours predicted higher mortality.\n",
    "Logistic regression confirmed the prognostic value of GES dynamics.\n",
    "\n",
    "Diagnostic and Prognostic Value:\n",
    "\n",
    "Diagnostic:Distinguishes infection from non-infectious systemic inflammation.\n",
    "Effective for point-of-care application.\n",
    "\n",
    "Prognostic:Changes in the DOWN genomic score over time associated with patient survival.\n",
    "\n",
    "\n",
    "## 3.  Predicting Sepsis Severity at First Clinical Presentation: The Role of Endotypes and Mechanistic Signatures\n",
    "\n",
    "\n",
    "Objective:\n",
    "\n",
    "Identify gene expression signatures that predict sepsis severity and mortality.\n",
    "Classify sepsis patients into distinct mechanistic endotypes to aid early diagnosis and treatment.\n",
    "\n",
    "\n",
    "Cohorts and Data Collection:\n",
    "\n",
    "Blood samples and clinical data collected from 348 patients across emergency rooms (ERs) and ICUs from different countries (Netherlands, Colombia, Canada, and Australia).\n",
    "RNA sequencing (RNA-Seq) used to analyze gene expression profiles.\n",
    "Data included 44 healthy controls for comparison.\n",
    "\n",
    "Analysis:\n",
    "\n",
    "Differential expression analysis using DESeq2.\n",
    "Logistic regression with least absolute shrinkage and selection operator (LASSO) for severity and mortality signature derivation.\n",
    "Machine learning techniques (k-medoids clustering) to classify patients into five distinct endotypes based on gene expression.\n",
    "Validation using external datasets.\n",
    "\n",
    "Signatures and Classification:\n",
    "\n",
    "Gene expression signatures developed for:\n",
    "Severity of disease.\n",
    "Mortality risk.\n",
    "Endotypes classified as Neutrophilic-Suppressive (NPS), Inflammatory (INF), Innate Host Defense (IHD), Interferon (IFN), and Adaptive (ADA).\n",
    "\n",
    "Results\n",
    "\n",
    "Gene Signatures:\n",
    "\n",
    "Severity and mortality signatures showed predictive accuracies (AUCs) of 77-80%.\n",
    "Pathways involved included neutrophil degranulation and interferon signaling.\n",
    "Network analysis revealed interconnected biological mechanisms across severity and mortality signatures.\n",
    "\n",
    "Endotypes:\n",
    "\n",
    "Five mechanistic endotypes were identified:\n",
    "NPS and INF associated with higher severity and mortality.\n",
    "IHD, IFN, and ADA were less severe.\n",
    "Endotypes predicted with a 40-gene classifier achieving 96% accuracy.\n",
    "\n",
    "Clinical Findings:\n",
    "\n",
    "NPS and INF endotypes had longer hospital stays, higher SOFA scores, and increased organ dysfunction.\n",
    "IFN endotype was associated with COVID-19-positive ICU patients.\n",
    "Endotypes persisted from early ER to ICU stages.\n",
    "\n",
    "Diagnostic and Prognostic Value\n",
    "\n",
    "The diagnostic genes identified in the study include **CEACAM1, S100A8, S100A9, CXCL10, IL1RN, MMP9, IFI44L, ELANE, CEACAM6, CXCL8 (IL-8), TNFAIP6, OAS1, HLA-DRA, CD74, TLR4, and PTX3**.\n",
    "\n",
    "The prognostic genes identified in the study include **CXCL10, IL1RN, MMP9, HLA-DRA, PTX3, OAS1, TNFAIP6, and CXCL8 (IL-8)**.\n",
    "\n",
    "\n",
    "## 4.  Expression Profiling: Toward an Application in Sepsis Diagnostics\n",
    "\n",
    "Objective:\n",
    "\n",
    "To assess whether transcriptional profiling of gene expression in whole blood can be applied to diagnose sepsis and provide a robust molecular signature for severe sepsis.\n",
    "\n",
    "Patient Enrollment:\n",
    "\n",
    "Sepsis Group: 8 patients with severe sepsis.\n",
    "\n",
    "Control Group: 4 patients who underwent spine surgery but showed no inflammatory symptoms.\n",
    "\n",
    "Blood samples were collected within 24 hours of sepsis diagnosis.\n",
    "\n",
    "RNA Isolation and Microarray Analysis:\n",
    "\n",
    "Total RNA extracted using PAXgene.\n",
    "RNA reverse transcribed to cDNA and labeled with Cy dyes.\n",
    "Hybridized to Lab-Arraytor® human 500-1 cDNA microarrays containing 340 genes relevant to inflammation.\n",
    "\n",
    "Data Analysis:Differentially expressed genes identified using a one-sample t-test with multiple testing corrections.\n",
    "A positive predictive value of 98% was used to select 50 key genes.\n",
    "\n",
    "Validation:RT-PCR was performed for selected genes (e.g., PF4, PPARG, S100A12) to confirm microarray findings.\n",
    "\n",
    "Key Findings:\n",
    "\n",
    "Gene Expression Analysis:\n",
    "\n",
    "224 out of 340 inflammation-related genes showed differential expression.\n",
    "A curated list of 50 significant genes with robust expression profiles was generated.\n",
    "Gene expression patterns were homogeneous across sepsis patients, despite their clinical heterogeneity.\n",
    "\n",
    "Upregulated Genes (Examples):\n",
    "\n",
    "**S100A8, S100A12** (calcium-binding proteins).\n",
    "\n",
    "**PF4** (Platelet Factor 4).\n",
    "\n",
    "**PPBP** (Pro-Platelet Basic Protein).\n",
    "\n",
    "Downregulated Genes (Examples):\n",
    "\n",
    "**CD36L1** (Thrombospondin receptor).\n",
    "\n",
    "**TNF** (Tumor Necrosis Factor).\n",
    "\n",
    "**IL6ST** (Interleukin 6 Signal Transducer).\n",
    "\n",
    "Cluster Analysis:\n",
    "Differentiated sepsis patients from controls with clear clustering patterns based on gene expression profiles.\n",
    "\n",
    "Diagnostic Value:\n",
    "\n",
    "Key Diagnostic Genes: **S100A8, S100A12, PF4**.\n",
    "\n",
    "Gene signatures demonstrated high predictive value, offering potential for sepsis diagnostics in clinical settings.\n",
    "Sensitivity and Specificity: Not explicitly provided but suggested to be high based on validation efforts.\n",
    "\n",
    "This study provides preliminary evidence that microarray-based transcriptional profiling can successfully identify a sepsis-specific gene expression signature. While promising for diagnostics, larger studies are needed to confirm findings and explore clinical applications.\n",
    "\n",
    "\n",
    "## 5. Presymptomatic diagnosis of postoperative infection and sepsis using gene expression signatures\n",
    "\n",
    "The study aimed to develop transcriptomic biomarkers for the presymptomatic diagnosis of postoperative infection and sepsis. By identifying gene expression changes preceding clinical onset, it seeks to facilitate earlier intervention and improve postoperative patient outcomes.\n",
    "\n",
    "\n",
    "Study Design and Population:\n",
    "\n",
    "Conducted a prospective multicenter study across eight hospitals.\n",
    "Included 4385 high-risk elective surgery patients.\n",
    "Identified 154 patients with confirmed postoperative infections, 98 of whom developed sepsis.\n",
    "Comparator cohorts included 148 patients with systemic inflammatory response syndrome (SIRS+) and 151 patients with an uncomplicated postoperative course (SIRS−).\n",
    "\n",
    "Sampling and Analysis:\n",
    "\n",
    "Blood samples collected daily pre- and postoperatively for up to seven days.\n",
    "Transcriptomic profiling:\n",
    "Microarray analysis for biomarker discovery.\n",
    "RT-qPCR verification for validation.\n",
    "\n",
    "Gene Discovery Process:\n",
    "\n",
    "Identified 2594 differentially expressed genes (DEGs) during the three days before infection diagnosis.\n",
    "Machine learning (random forest algorithm) selected key biomarkers.\n",
    "\n",
    "Gene sets were refined:\n",
    "\n",
    "7 genes for infection vs. SIRS− (e.g., B4GALT5, TRPM2).\n",
    "12 genes for infection vs. SIRS+ (e.g., MED13L, CFLAR).\n",
    "8 genes for sepsis vs. uncomplicated infection (e.g., DOK3, IL1R1).\n",
    "\n",
    "Machine Learning Models:\n",
    "\n",
    "Random forest classifiers developed for each gene set.\n",
    "Performance evaluated using cross-validation and receiver operating characteristic (ROC) curves.\n",
    "\n",
    "Results\n",
    "\n",
    "Diagnostic Performance:\n",
    "\n",
    "7-gene signature for infection vs. SIRS−:\n",
    "AUC: 0.871.\n",
    "Sensitivity: High.\n",
    "Specificity: Moderate.\n",
    "\n",
    "12-gene signature for infection vs. SIRS+:\n",
    "AUC: 0.897.\n",
    "Sensitivity: High.\n",
    "Specificity: High.\n",
    "\n",
    "8-gene signature for sepsis vs. uncomplicated infection:\n",
    "AUC: 0.703.\n",
    "Sensitivity: High.\n",
    "Specificity: Low.\n",
    "\n",
    "Clinical Implications:\n",
    "Early identification of infection and sepsis up to three days before clinical symptoms.\n",
    "Differentiation between infectious and non-infectious inflammation.\n",
    "Moderate discrimination between sepsis and uncomplicated infection.\n",
    "\n",
    "Diagnostic and Prognostic Value\n",
    "\n",
    "Diagnostic:\n",
    "Gene panels (7, 12, and 8 genes) enable presymptomatic detection of infection and sepsis.\n",
    "High sensitivity offers potential for clinical applications, particularly in at-risk surgical populations.\n",
    "\n",
    "\n",
    "This study highlights the potential of small gene sets for presymptomatic diagnosis of sepsis, paving the way for improved postoperative management and early therapeutic intervention. \n",
    "If validated further, this approach could significantly enhance clinical decision-making in high-risk surgical patients.\n",
    "\n",
    "7-Gene Signature (for distinguishing infection from non-infected postoperative controls): **B4GALT5, AFF1, LDLR, ATXN7L3, LARP4B, SLC36A1, TRPM2.**\n",
    "\n",
    "12-Gene Signature (for infection vs. SIRS+ inflammation):**ATXN1, SLC41A3, MED13L, STOM, B4GALT5, MIDN, HVCN1, LDLR, CFLAR, SPATA13, EIF4G3, METTL7B.**\n",
    "\n",
    "8-Gene Signature (for sepsis vs. uncomplicated infection):**DOK3, ICAM2, IL1R1, LGALS2, LSG1, RPL13A, RPS13, SGSH**\n",
    "\n",
    "\n",
    "## 6.  A community approach to mortality prediction in sepsis via gene expression analysis\" focuses on using gene expression profiling to create prognostic models for predicting 30-day mortality in sepsis patients. \n",
    "\n",
    "Objective:\n",
    "\n",
    "To develop and validate gene-expression-based models for predicting 30-day mortality in sepsis patients, improving over traditional clinical severity scores.\n",
    "\n",
    "Cohorts:\n",
    "\n",
    "12 discovery cohorts (485 survivors, 157 non-survivors).\n",
    "Validation in 5 community-acquired sepsis cohorts and 4 hospital-acquired infection cohorts.\n",
    "\n",
    "Gene Expression Data:\n",
    "Whole-blood transcriptomic data from 21 cohorts of sepsis patients.\n",
    "Normalization and preprocessing of microarray and RNAseq data.\n",
    "\n",
    "Model Development:\n",
    "\n",
    "Three independent research groups (Duke, Sage Bionetworks, and Stanford) developed four different models using:\n",
    "Difference-of-means formula.\n",
    "Penalized logistic regression.\n",
    "Random Forest.\n",
    "Each model selected genes based on their ability to predict mortality.\n",
    "\n",
    "Validation Metrics:\n",
    "Area Under the Receiver Operating Characteristic Curve (AUROC).\n",
    "Net Reclassification Improvement (NRI) index.\n",
    "Ensemble models to evaluate combined predictive power.\n",
    "\n",
    "Enrichment Analysis:\n",
    "Identified biological pathways linked to mortality-associated genes.\n",
    "\n",
    "Results:\n",
    "\n",
    "Prognostic Accuracy:AUROCs for models ranged from 0.75 to 0.89 in community-acquired sepsis cohorts.\n",
    "Similar performance in hospital-acquired infection cohorts (AUROCs: 0.81–0.87).\n",
    "\n",
    "Gene Signatures:\n",
    "\n",
    "Each model identified unique sets of genes predictive of mortality. Example genes include:\n",
    "\n",
    "Upregulated: **TRIB1, DEFA4, HIF1A, SEPP1**.\n",
    "\n",
    "Downregulated: **LY86, TST, NT5E, CX3CR1**.\n",
    "\n",
    "Combination with Clinical Scores:\n",
    "\n",
    "Adding gene expression models to traditional clinical severity scores significantly improved prognostic performance.\n",
    "\n",
    "Biological Insights:Enriched pathways included T-cell activation, cytokine signaling, and inflammation-related processes.\n",
    "Identified genes linked to neutrophil proteases, immune exhaustion, and hypoxia.\n",
    "\n",
    "The prognostic models aimed to stratify sepsis patients based on their risk of 30-day mortality.\n",
    "Key Prognostic Genes:\n",
    "\n",
    "Upregulated in non-survivors: **TRIB1, DEFA4, HIF1A, SEPP1, CD163, RGS1, BPI, MPO, DDIT4**.\n",
    "\n",
    "Downregulated in non-survivors: **LY86, TST, NT5E, CX3CR1, CD5, AIM2, GSTM1**.\n",
    "\n",
    "\n",
    "## 7. Differential Gene Expression in Gram-negative and Gram-positive Sepsis \n",
    "\n",
    "\n",
    "Objective:\n",
    "\n",
    "To identify differential gene expression in the liver during gram-negative (E. coli) and gram-positive (S. aureus) sepsis.\n",
    "\n",
    "Experimental Design:\n",
    "\n",
    "Subjects: 60 septic BALB/c mice (E. coli and S. aureus groups) and 6 uninfected controls.\n",
    "Time Points: Samples collected at 2, 8, 24, 48, and 72 hours post-infection.\n",
    "\n",
    "Techniques:\n",
    "Microarray Analysis: Genome-wide cDNA microarray containing 6,144 genes.\n",
    "Northern Blot Validation: Validation of selected differentially expressed genes.\n",
    "Immunohistochemistry: Analysis of protein-level expression of specific genes in liver tissues.\n",
    "Apoptosis Assay: Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) for apoptosis detection.\n",
    "\n",
    "Bioinformatics:\n",
    "Gene clustering using self-organizing maps and hierarchical clustering.\n",
    "Functional annotation of genes into categories like inflammation, apoptosis, and metabolism.\n",
    "Statistical analysis for significant expression changes and differential expression.\n",
    "\n",
    "Results\n",
    "\n",
    "Gene Expression Changes:4.8% of the analyzed genes (approximately 295 genes) showed a significant twofold change in expression.\n",
    "Common genes between gram-negative and gram-positive sepsis were observed, but 17 genes exhibited distinct expression patterns.\n",
    "\n",
    "Categories of Genes:\n",
    "\n",
    "Inflammation and Defense: Upregulation of immune response genes like MHC molecules, complement proteins.\n",
    "\n",
    "Antioxidation and Detoxification: Downregulation of glutathione-S-transferases and cytochrome P450 genes.\n",
    "\n",
    "Vesicle Trafficking and Transport: Altered expression of genes involved in protein sorting and nutrient transport.\n",
    "\n",
    "Cell Signaling and Apoptosis: Differential regulation of Notch signaling and apoptosis-related genes.\n",
    "\n",
    "Apoptosis:\n",
    "\n",
    "Kupffer cells exhibited higher rates of apoptosis in gram-negative sepsis compared to gram-positive sepsis.\n",
    "Differential Genes in E. coli vs. S. aureus Sepsis:\n",
    "Examples include GBP-2 (upregulated in gram-negative sepsis) and C-type lectin (higher in gram-positive sepsis).\n",
    "\n",
    "Diagnostic and Prognostic Genes\n",
    "\n",
    "Diagnostic Genes:\n",
    "Genes identified as potential diagnostic markers due to their upregulation in response to both gram-negative and gram-positive sepsis:\n",
    "\n",
    "**GBP-2** (Guanylate-Binding Protein-2): High expression in gram-negative sepsis.\n",
    "**C-Type Lectin**: Relevant in immune responses to gram-positive pathogens.\n",
    "\n",
    "Prognostic Genes:\n",
    "\n",
    "Genes with a role in the severity and progression of sepsis:\n",
    "\n",
    "**IκB-β** (Inhibitor of NF-κB β Chain): Elevated early in infection, limiting excessive immune responses.\n",
    "\n",
    "**C/EBP-β** and **C/EBP-δ** (CCAAT/Enhancer-Binding Proteins): Altered to regulate hematopoiesis during infection.\n",
    "\n",
    "Notch Pathway Genes (**Sel1, Itch**): Implicated in immune cell proliferation.\n",
    "\n",
    "\n",
    "## 8. Identification of apoptosis-immune-related gene signature and construction of diagnostic model for sepsis based on single-cell sequencing and bulk transcriptome analysis\n",
    "\n",
    "Objective\n",
    "\n",
    "The study aimed to identify apoptosis-immune-related gene signatures and construct diagnostic and prognostic models for sepsis through single-cell and bulk transcriptome analyses.\n",
    "\n",
    "Data Acquisition:\n",
    "\n",
    "Gene expression datasets (GSE65682, GSE13904, GSE26378) were retrieved from the GEO database.\n",
    "Apoptosis-related genes were obtained from the KEGG database.\n",
    "\n",
    "Gene Identification:\n",
    "LASSO regression and SVM-RFE algorithms were used to identify differentially expressed genes (DEGs) for sepsis.\n",
    "\n",
    "Functional Enrichment:\n",
    "GO and KEGG pathway analyses were performed to study apoptosis-related pathways in sepsis.\n",
    "\n",
    "Model Construction:\n",
    "Diagnostic and prognostic models were created using regression algorithms.\n",
    "Immune infiltration analysis and single-cell RNA sequencing (scRNA-seq) data were analyzed.\n",
    "\n",
    "Validation:\n",
    "Hub genes were validated in external datasets and animal models using RT-qPCR, IHC, and ROC analysis.\n",
    "\n",
    "Key Results\n",
    "\n",
    "Diagnostic Genes:\n",
    "\n",
    "Eleven apoptosis-related DEGs were identified: CASP8, VDAC2, CHMP1A, CHMP5, FASLG, IFNAR1, JAK1, JAK3, STAT4, IRF9, and BCL2.\n",
    "\n",
    "ROC curves indicated a high diagnostic value for nine of these genes.\n",
    "\n",
    "Prognostic Genes:\n",
    "\n",
    "Four hub genes (BCL2, FASLG, JAK3, and IRF9) were identified as prognostic markers.\n",
    "\n",
    "Time-ROC analyses showed the prognostic significance of these genes over 1-, 2-, and 3-week periods.\n",
    "\n",
    "Immune Landscape:Apoptosis-related genes were strongly linked to immune system changes in sepsis.\n",
    "Correlations between hub genes and immune cell types, such as T cells and B cells, were observed.\n",
    "\n",
    "Validation in Mouse Model:\n",
    "\n",
    "Differential gene expression was confirmed in serum and tissues (heart, lung, liver, and kidney).\n",
    "\n",
    "Gene-Level or Protein-Level Analysis\n",
    "Primary Level: Gene expression analysis was performed using transcriptomics.\n",
    "Validation Level: Protein expression was confirmed through IHC.\n",
    "\n",
    "Diagnostic and Prognostic Genes\n",
    "\n",
    "Diagnostic:**CASP8, VDAC2, CHMP1A, CHMP5, FASLG, IFNAR1, JAK1, JAK3, STAT4, IRF9, BCL2**.\n",
    "\n",
    "Prognostic:**BCL2, FASLG, JAK3, IRF9**.\n",
    "\n",
    "\n",
    "## 9. Development of a Bioinformatics Framework for Identification and Validation of Genomic Biomarkers and Key Immunopathology Processes and Controllers in Infectious and Non-infectious Severe Inflammatory Response Syndrome\n",
    "\n",
    "Data Collection:\n",
    "\n",
    "Microarray datasets were obtained from ArrayExpress.\n",
    "Data included samples from SIRS, sepsis, septic shock, resolved SIRS, gram-positive/negative bacterial infections, and healthy controls.\n",
    "A total of 401 samples from four datasets were analyzed.\n",
    "\n",
    "Data Preprocessing:\n",
    "Raw data normalized using robust multi-array average (RMA) processing.\n",
    "Filtering to identify unique, consistent gene symbols across datasets.\n",
    "\n",
    "Gene Screening:\n",
    "Two-tier screening using artificial neural network (ANN) models.\n",
    "Initial selection of 48 candidate genes associated with sepsis and SIRS.\n",
    "Identification of housekeeping genes for normalization.\n",
    "\n",
    "Gene Interaction Analysis:\n",
    "Used ANN-based inference algorithms to map relationships between genes.\n",
    "Interaction maps created using Cytoscape.\n",
    "\n",
    "Functional Pathway Analysis:\n",
    "Pathways analyzed using the PANTHER database and GeneSpring software.\n",
    "Statistical analysis with ANOVA to identify significant gene expression patterns.\n",
    "\n",
    "Hub Gene Identification:\n",
    "\n",
    "Eight hub genes identified: CD177, GPR84, FGF13, KLRK1, MYL9, PCOLCE2, TDRD9, and SLC16A3.\n",
    "\n",
    "Genes examined for their ability to stratify disease states (e.g., SIRS vs. sepsis).\n",
    "\n",
    "Results:\n",
    "\n",
    "Diagnostic Biomarkers:\n",
    "\n",
    "**CD177, GPR84, and MYL9** were key biomarkers showing differential expression in SIRS and sepsis.\n",
    "Significant overlaps in pathways were observed between pediatric and adult sepsis.\n",
    "\n",
    "Gene-Pathway Interactions:\n",
    "Interaction maps revealed distinct immune responses in sepsis and SIRS.\n",
    "GPR84 was linked to pro-inflammatory pathways, while CD177 regulated neutrophil activity.\n",
    "\n",
    "Pathway Analysis:\n",
    "Identified 82 pathways associated with sepsis and SIRS, including signal transduction, immune response, and cell growth pathways.\n",
    "\n",
    "Immune Cell Associations:\n",
    "Genes like CD177 and MYL9 were linked to neutrophil activity.\n",
    "GPR84 indicated inflammatory processes in monocytes and macrophages.\n",
    "\n",
    "Diagnostic Genes:\n",
    "The study identified **CD177, GPR84, MYL9, PCOLCE2, TDRD9, SLC16A3, FGF13, and KLRK1** as potential diagnostic biomarkers for sepsis and SIRS differentiation.\n",
    "\n",
    "\n",
    "## 10. Exploring the prognostic and diagnostic value of lactylation-related genes in sepsis\n",
    "\n",
    "Objectives:\n",
    "\n",
    "To investigate the prognostic and diagnostic potential of lactylation-related genes in sepsis by analyzing RNA sequencing data and identifying lactylation-related gene biomarkers.\n",
    "\n",
    "Study Design:\n",
    "\n",
    "Peripheral blood samples from 20 sepsis patients and 10 healthy controls were collected.\n",
    "RNA sequencing was performed to identify differentially expressed genes (DEGs).\n",
    "\n",
    "Selection of Lactylation Genes:DEGs were compared to a database of 332 known lactylation genes, identifying 55 lactylation-related genes associated with sepsis.\n",
    "\n",
    "Functional Analysis:Gene Ontology (GO) and KEGG Pathway Analysis were conducted to assess the functions and pathways associated with the identified genes.\n",
    "\n",
    "Protein-Protein Interaction (PPI) Network:PPI network analysis was conducted to identify core genes central to sepsis-related lactylation processes.\n",
    "\n",
    "Survival Analysis:Survival data from the GEO dataset GSE65682 (478 sepsis patients) were analyzed to link gene expression with 28-day survival rates.\n",
    "\n",
    "ROC Curve Analysis:Diagnostic potential was assessed using the GEO dataset GSE69528 for sensitivity and specificity.\n",
    "\n",
    "Meta-Analysis:Validation of findings using public datasets (GSE54514, GSE63042, and GSE95233) to evaluate gene expression across different sepsis cohorts.\n",
    "\n",
    "Single-Cell RNA Sequencing:Peripheral blood mononuclear cells (PBMCs) from 5 samples (sepsis, SIRS, and healthy controls) were analyzed to identify cellular expression patterns of key genes.\n",
    "\n",
    "Key Results:\n",
    "\n",
    "Diagnostic and Prognostic Genes:\n",
    "\n",
    "S100A11:Prognostic: High expression correlated with better 28-day survival rates in sepsis.Diagnostic: High sensitivity and specificity (AUC = 0.961 in ROC analysis).\n",
    "\n",
    "CCNA2:Prognostic: Low expression associated with improved survival rates.Diagnostic: High diagnostic accuracy (AUC = 0.890 in ROC analysis).\n",
    "\n",
    "Functional Insights:\n",
    "GO Analysis:Genes enriched in cellular adhesion and regulation-related biological processes.\n",
    "\n",
    "KEGG Pathways:Significant involvement in amino acid metabolism and immune system pathways.\n",
    "\n",
    "Meta-Analysis Validation:Consistent expression trends were observed across multiple datasets:\n",
    "\n",
    "**S100A11**: High in survivors, low in non-survivors.\n",
    "\n",
    "**CCNA2**: High in non-survivors, low in survivors.\n",
    "\n",
    "Cellular Localization:\n",
    "Single-cell RNA sequencing identified:\n",
    "S100A11 expression in monocyte/macrophages and T cells.\n",
    "CCNA2 expression in NK cells, T cells, and B cells.\n",
    "\n",
    "Diagnostic Genes for Sepsis:\n",
    "S100A11 and CCNA2 are highlighted as key diagnostic markers with robust sensitivity and specificity based on ROC analysis.\n",
    "\n",
    "Prognostic Genes for Sepsis:\n",
    "S100A11: High expression predicts better outcomes.\n",
    "CCNA2: Low expression correlates with higher survival rates.\n",
    "\n",
    "## 11. Key platelet genes play important roles in predicting the prognosis of sepsis\n",
    "\n",
    "Objective:\n",
    "\n",
    "The study aims to identify key platelet-associated genes through single-cell RNA sequencing (scRNA-seq) and bulk RNA sequencing (bulk RNA-seq) data to construct a stable prognostic model for sepsis.\n",
    "\n",
    "Data Sources:\n",
    "scRNA-seq and bulk RNA-seq datasets from sepsis patients were sourced from the Gene Expression Omnibus (GEO).\n",
    "Clinical data of patients were analyzed alongside transcriptomic data.\n",
    "\n",
    "scRNA-seq Analysis:\n",
    "Data processing using the Seurat R package.\n",
    "Quality control and dimensionality reduction using UMAP and Harmony.\n",
    "Identification of cell clusters and marker genes.\n",
    "Cell communication analysis using CellChat.\n",
    "Pseudo-time trajectory analysis using Monocle.\n",
    "\n",
    "Bulk RNA-seq Analysis:\n",
    "Differentially expressed genes (DEGs) identified using the \"limma\" package.\n",
    "Functional enrichment analysis via GO, KEGG, and GSEA.\n",
    "Weighted Gene Correlation Network Analysis (WGCNA):\n",
    "Modules of co-expressed genes were identified.\n",
    "Modules were correlated with clinical traits.\n",
    "\n",
    "Prognostic Model Construction:\n",
    "Genes from scRNA-seq and bulk RNA-seq were intersected.\n",
    "Univariate and multivariate Cox regression and machine learning algorithms were used to identify prognostic genes.\n",
    "Model validation with survival analysis and ROC curves.\n",
    "\n",
    "Experimental Validation:\n",
    "qRT-PCR conducted on a mouse model of cecal ligation and puncture (CLP)-induced sepsis.\n",
    "Gene expression differences validated between sepsis and sham groups.\n",
    "\n",
    "Results:\n",
    "\n",
    "Key Findings in scRNA-seq:\n",
    "Identified increased interactions between platelets and immune cells in sepsis patients.\n",
    "Platelet-associated gene markers were prioritized for analysis.\n",
    "\n",
    "Prognostic Model:\n",
    "\n",
    "Ten prognostic genes identified: **CD36, FOS, RPL11, SAT1, CTSW, MAP3K7, GIMAP4, TRAIL, CD93, PPDPF**.\n",
    "\n",
    "High-risk patients had poorer survival and reduced immune cell infiltration.\n",
    "The prognostic model showed strong predictive performance with AUC values of 0.88, 0.84, and 0.83 for survival at 1, 2, and 3 weeks.\n",
    "\n",
    "Experimental Validation:\n",
    "Five genes (**CD36, CD93, GIMAP4, PPDPF, MAP3K7) were significantly differentially expressed** in the sepsis group versus controls.\n",
    "\n",
    "Biological Insights:\n",
    "Platelets were crucial in immune modulation and inflammation during sepsis.\n",
    "DEGs were enriched in pathways related to immune response, inflammation, and platelet function.\n",
    "\n",
    "\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.16"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
